Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Use of continuous venovenous hemofiltration for acute renal failure due to multiple myeloma cast nephropathy.

Mehta S, Shtaynberg N, Goldman M, Asti D, Kiroycheva M, Pepe J.

Hematology. 2012 Jul;17(4):229-31. doi: 10.1179/1607845412Y.0000000003.

PMID:
22889516
2.

Impact of free light chain hemodialysis in myeloma cast nephropathy: a case-control study.

Peters NO, Laurain E, Cridlig J, Hulin C, Cao-Huu T, Frimat L.

Hemodial Int. 2011 Oct;15(4):538-45. doi: 10.1111/j.1542-4758.2011.00587.x. Epub 2011 Aug 16.

PMID:
22111823
3.

Paraprotein-Related Kidney Disease: Evaluation and Treatment of Myeloma Cast Nephropathy.

Finkel KW, Cohen EP, Shirali A, Abudayyeh A; American Society of Nephrology Onco-Nephrology Forum.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2273-2279. Epub 2016 Aug 15.

4.

Treatment by long haemodialysis sessions with high cut-off filters in myeloma cast nephropathy: our experience.

Borrego-Hinojosa J, Pérez-del Barrio MP, Biechy-Baldan Mdel M, Merino-García E, Sánchez-Perales MC, García-Cortés MJ, Ocaña-Pérez E, Gutiérrez-Rivas P, Liébana-Cañada A.

Nefrologia. 2013;33(4):515-23. doi: 10.3265/Nefrologia.pre2013.Feb.11932. English, Spanish.

5.

Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy.

Hasegawa M, Kondo F, Yamamoto K, Murakami K, Tomita M, Nabeshima K, Nakai S, Kato M, Ohashi A, Arai J, Hiki Y, Ishii J, Emi N, Sugiyama S, Yuzawa Y.

Ther Apher Dial. 2010 Oct;14(5):451-6. doi: 10.1111/j.1744-9987.2010.00863.x.

PMID:
21175542
6.

Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis.

Hutchison CA, Bradwell AR, Cook M, Basnayake K, Basu S, Harding S, Hattersley J, Evans ND, Chappel MJ, Sampson P, Foggensteiner L, Adu D, Cockwell P.

Clin J Am Soc Nephrol. 2009 Apr;4(4):745-54. doi: 10.2215/CJN.04590908. Epub 2009 Apr 1.

7.

Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy.

Rousseau-Gagnon M, Agharazii M, De Serres SA, Desmeules S.

PLoS One. 2015 Oct 14;10(10):e0140463. doi: 10.1371/journal.pone.0140463. eCollection 2015.

8.

Management options for cast nephropathy in multiple myeloma.

Cockwell P, Hutchison CA.

Curr Opin Nephrol Hypertens. 2010 Nov;19(6):550-5. doi: 10.1097/MNH.0b013e32833ef72c. Review.

PMID:
20827195
9.

Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical Trial.

Bridoux F, Carron PL, Pegourie B, Alamartine E, Augeul-Meunier K, Karras A, Joly B, Peraldi MN, Arnulf B, Vigneau C, Lamy T, Wynckel A, Kolb B, Royer B, Rabot N, Benboubker L, Combe C, Jaccard A, Moulin B, Knebelmann B, Chevret S, Fermand JP; MYRE Study Group.

JAMA. 2017 Dec 5;318(21):2099-2110. doi: 10.1001/jama.2017.17924.

PMID:
29209721
10.

Cast nephropathy with acute renal failure treated with high cut-off haemodialysis in a patient with multiple myeloma.

Shum HP, Chan KC, Chow CC, Kho BC, Yan WW.

Hong Kong Med J. 2010 Dec;16(6):489-92.

11.

The rationale and evidence base for the direct removal of serum-free light chains in the management of myeloma kidney.

Cockwell P, Cook M.

Adv Chronic Kidney Dis. 2012 Sep;19(5):324-32. doi: 10.1053/j.ackd.2012.06.003. Review.

PMID:
22920643
12.

Treatment of acute kidney injury with cast nephropathy.

Walther C, Podoll AS, Finkel KW.

Clin Nephrol. 2014 Jul;82(1):1-6. doi: 10.5414/CN108293. Review.

PMID:
24725380
13.

Recovery of kidney function following delayed use of Theralite™ dialyzer in a patient with myeloma cast nephropathy.

Dahal K, Shastri S, Narayanasami U, Bijol V, Rider K, Strom JA, Jaber BL.

Clin Nephrol. 2013 Apr;79(4):318-22. doi: 10.5414/CN107357.

PMID:
22541683
14.

Optimizing treatment strategies in myeloma cast nephropathy: rationale for a randomized prospective trial.

Bridoux F, Fermand JP.

Adv Chronic Kidney Dis. 2012 Sep;19(5):333-41. doi: 10.1053/j.ackd.2012.07.003. Review.

PMID:
22920644
15.

[Improved prognosis in light chain nephropathy due to multiple myeloma].

Juul JS, Larsen T, Marcussen N, Pedersen EB.

Ugeskr Laeger. 2012 Apr 23;174(17):1159-60. Danish.

PMID:
22533933
16.

Approach to acute renal failure in biopsy proven myeloma cast nephropathy: is there still a role for plasmapheresis?

Pillon L, Sweeting RS, Arora A, Notkin A, Ballard HS, Wieczorek RL, Leung N.

Kidney Int. 2008 Oct;74(7):956-61. doi: 10.1038/ki.2008.138. Epub 2008 Apr 16. No abstract available.

17.

Extracorporeal light chain elimination: high cut-off (HCO) hemodialysis parallel to chemotherapy allows for a high proportion of renal recovery in multiple myeloma patients with dialysis-dependent acute kidney injury.

Heyne N, Denecke B, Guthoff M, Oehrlein K, Kanz L, Häring HU, Weisel KC.

Ann Hematol. 2012 May;91(5):729-735. doi: 10.1007/s00277-011-1383-0. Epub 2011 Dec 15.

PMID:
22170517
18.

[Withdrawal of maintenance dialysis in a patient with diagnosed multiple myeloma and renal failure as a consequence of effective anti-tumor treatment].

Rosa J, Sydor A, Jurczyszyn A, Zabawa-Hołyś S, Nowak J, Czapkowicz-Gryszkiewicz L, Sułowicz W.

Przegl Lek. 2010;67(7):547-50. Polish.

PMID:
21387773
19.

Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis.

Hutchison CA, Heyne N, Airia P, Schindler R, Zickler D, Cook M, Cockwell P, Grima D.

Nephrol Dial Transplant. 2012 Oct;27(10):3823-8. doi: 10.1093/ndt/gfr773. Epub 2012 Jan 23.

PMID:
22273664
20.

Supplemental Content

Support Center